Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?

BACKGROUND: For acute myeloid leukemia (AML) patients, the role of bridging consolidation chemotherapy after achieving first complete remission (CR1) in the transplant setting is a frequently debated issue. The lack of data from Asian patients led us to conduct this study. METHODS: We retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Ja Min, Shin, Dong-Yeop, Koh, Youngil, Hong, Junshik, Kim, Inho, Yoon, Sung-Soo, Bang, Soo-Mee, Lee, Jeong-Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060779/
https://www.ncbi.nlm.nih.gov/pubmed/33959243
http://dx.doi.org/10.1177/20406207211001135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060779/
https://www.ncbi.nlm.nih.gov/pubmed/33959243
http://dx.doi.org/10.1177/20406207211001135

Ejemplares similares